Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Phospholipid transfer protein is regulated by liver X receptors in vivo.

Cao G, Beyer TP, Yang XP, Schmidt RJ, Zhang Y, Bensch WR, Kauffman RF, Gao H, Ryan TP, Liang Y, Eacho PI, Jiang XC.

J Biol Chem. 2002 Oct 18;277(42):39561-5. Epub 2002 Aug 9.

2.

The impact of phospholipid transfer protein (PLTP) on HDL metabolism.

Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C.

Atherosclerosis. 2001 Apr;155(2):269-81. Review.

PMID:
11254896
3.

Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport.

Yazdanyar A, Yeang C, Jiang XC.

Curr Atheroscler Rep. 2011 Jun;13(3):242-8. doi: 10.1007/s11883-011-0172-5. Review.

4.

Liver X receptors (LXR) as therapeutic targets in dyslipidemia.

Bełtowski J.

Cardiovasc Ther. 2008 Winter;26(4):297-316. doi: 10.1111/j.1755-5922.2008.00062.x. Review.

PMID:
19035881
5.

Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.

Wójcicka G, Jamroz-Wiśniewska A, Horoszewicz K, Bełtowski J.

Postepy Hig Med Dosw (Online). 2007 Dec 3;61:736-59. Review.

6.

New insights into the regulation of HDL metabolism and reverse cholesterol transport.

Lewis GF, Rader DJ.

Circ Res. 2005 Jun 24;96(12):1221-32. Review.

7.

Is there a genetic basis for resistance to atherosclerosis?

Stein O, Thiery J, Stein Y.

Atherosclerosis. 2002 Jan;160(1):1-10. Review.

PMID:
11755917
8.

Nuclear receptors as potential targets for modulating reverse cholesterol transport.

Pelton PD, Patel M, Demarest KT.

Curr Top Med Chem. 2005;5(3):265-82. Review.

PMID:
15857310
9.

The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.

Niesor EJ, Flach J, Lopes-Antoni I, Perez A, Bentzen CL.

Curr Pharm Des. 2001 Mar;7(4):231-59. Review.

PMID:
11254888
10.

LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis.

Edwards PA, Kennedy MA, Mak PA.

Vascul Pharmacol. 2002 Apr;38(4):249-56. Review.

PMID:
12449021
11.

New targets of high-density lipoprotein therapy.

Nicholls SJ, Nissen SE.

Curr Opin Lipidol. 2007 Aug;18(4):421-6. Review.

PMID:
17620859
12.

LXR agonists for the treatment of atherosclerosis.

Jaye M.

Curr Opin Investig Drugs. 2003 Sep;4(9):1053-8. Review.

PMID:
14582448
13.

Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.

Millatt LJ, Bocher V, Fruchart JC, Staels B.

Biochim Biophys Acta. 2003 Mar 17;1631(2):107-18. Review.

PMID:
12633677
14.

Liver X receptors as therapeutic targets in metabolism and atherosclerosis.

Nomiyama T, Bruemmer D.

Curr Atheroscler Rep. 2008 Feb;10(1):88-95. Review.

PMID:
18366990
15.

Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages.

Töröcsik D, Szanto A, Nagy L.

Mol Aspects Med. 2009 Jun;30(3):134-52. doi: 10.1016/j.mam.2009.02.002. Epub 2009 Feb 25. Review.

PMID:
19248804
16.

The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.

Kiss M, Czimmerer Z, Nagy L.

J Allergy Clin Immunol. 2013 Aug;132(2):264-86. doi: 10.1016/j.jaci.2013.05.044. Review.

PMID:
23905916
17.

[Regulation of serum HDL cholesterol and prevention of atherosclerosis].

Kahri J.

Duodecim. 2002;118(18):1863-71. Review. Finnish. No abstract available.

PMID:
12422668
18.

Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism.

Lu TT, Repa JJ, Mangelsdorf DJ.

J Biol Chem. 2001 Oct 12;276(41):37735-8. Epub 2001 Jul 17. Review. No abstract available.

19.

Pharmacological evidence for a role of liver X receptors in atheroprotection.

Kovanen PT, Pentikäinen MO.

FEBS Lett. 2003 Feb 11;536(1-3):3-5. Review. No abstract available.

20.

Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.

Chinetti G, Fruchart JC, Staels B.

Biochem Soc Trans. 2006 Dec;34(Pt 6):1128-31. Review. Erratum in: Biochem Soc Trans. 2007 Feb;35(Pt 1):165.

PMID:
17073767

Supplemental Content

Support Center